These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 6252018)
1. Regulation of receptor binding interactions of 125I-angiotensin II and 125I-[sarcosine1,leucine8]angiotensin II, an angiotensin antagonist, by sodium ion. Bennett JP; Snyder SH Eur J Pharmacol; 1980 Oct; 67(1):1-10. PubMed ID: 6252018 [TBL] [Abstract][Full Text] [Related]
2. Receptor binding interactions of the angiotensin II antagonist, 125I-[sarcosine1,leucine8]angiotensin II, with mammalian brain and peripheral tissues. Bennett JP; Snyder SH Eur J Pharmacol; 1980 Oct; 67(1):11-25. PubMed ID: 6252019 [TBL] [Abstract][Full Text] [Related]
3. Studies on inhibition of angiotensin II receptors in rabbit adrenal and aorta. Pendleton RG; Gessner G; Horner E J Pharmacol Exp Ther; 1989 Feb; 248(2):637-43. PubMed ID: 2918473 [TBL] [Abstract][Full Text] [Related]
4. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa. De Léan A; Ong H; Gutkowska J; Schiller PW; McNicoll N Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899 [TBL] [Abstract][Full Text] [Related]
5. Identification of selective, high affinity [125I]-angiotensin and [125I]-bradykinin binding sites in rat intestinal epithelia. Cox HM; Munday KA; Poat JA Br J Pharmacol; 1986 Jan; 87(1):201-9. PubMed ID: 2869810 [TBL] [Abstract][Full Text] [Related]
7. Reciprocal modulation of the binding of angiotensin agonists and antagonists to angiotensin receptors in smooth muscle. Koziarz P; Beck J; Moore GJ Gen Pharmacol; 1993 May; 24(3):705-13. PubMed ID: 8365653 [TBL] [Abstract][Full Text] [Related]
8. Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8. Hsieh KH; LaHann TR; Speth RC J Med Chem; 1989 Apr; 32(4):898-903. PubMed ID: 2704034 [TBL] [Abstract][Full Text] [Related]
9. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies. Wienen W; Mauz AB; Van Meel JC; Entzeroth M Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410 [TBL] [Abstract][Full Text] [Related]
10. Characterization of bovine ovary angiotensin II receptors using subtype-selective antagonists. Aiyar N; Griffin E; Edwards R; Weinstock J; Samanen J; Nambi P Pharmacology; 1993; 46(1):1-8. PubMed ID: 8434027 [TBL] [Abstract][Full Text] [Related]
11. Chronic estradiol treatment decreases angiotensin II receptor density in the anterior pituitary gland and adrenal cortex but not in the mesenteric artery. Carrière PD; De Léan A; Gutkowska J; Genest J; Cantin M Neuroendocrinology; 1986; 43(1):49-56. PubMed ID: 3012393 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla. Balla T; Baukal AJ; Eng S; Catt KJ Mol Pharmacol; 1991 Sep; 40(3):401-6. PubMed ID: 1654513 [TBL] [Abstract][Full Text] [Related]
13. AT1 receptor characteristics of angiotensin analogue binding in human synovium. Walsh DA; Suzuki T; Knock GA; Blake DR; Polak JM; Wharton J Br J Pharmacol; 1994 Jun; 112(2):435-42. PubMed ID: 8075862 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of cations and guanyl nucleotides on agonist and antagonist binding to rat adrenal and uterine angiotensin II receptors. Capponi AM; Van KH; Vallotton MB Eur J Pharmacol; 1985 Aug; 114(3):325-33. PubMed ID: 2998811 [TBL] [Abstract][Full Text] [Related]
15. Quantitative autoradiography of 125I-[Sar1, Ile8]-angiotensin II binding in the brain of spontaneously hypertensive rats. Hwang BH; Harding JW; Liu DK; Hibbard LS; Wieczorek CM; Wu JY Brain Res Bull; 1986 Jan; 16(1):75-82. PubMed ID: 3006878 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues. Pendleton RG; Gessner G; Horner E J Pharmacol Exp Ther; 1991 Feb; 256(2):614-20. PubMed ID: 1993998 [TBL] [Abstract][Full Text] [Related]
17. Covalent crosslinking of angiotensin II to its binding sites in rat adrenal membranes. Paglin S; Jamieson JD Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3739-43. PubMed ID: 6285362 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist. Noda M; Shibouta Y; Inada Y; Ojima M; Wada T; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K Biochem Pharmacol; 1993 Jul; 46(2):311-8. PubMed ID: 8347154 [TBL] [Abstract][Full Text] [Related]
19. Dissociation of increases in intracellular calcium and aldosterone production induced by angiotensin II (AII): evidence for regulation by distinct AII receptor subtypes or isomorphs. Kocsis JF; Schimmel RJ; McIlroy PJ; Carsia RV Endocrinology; 1995 Apr; 136(4):1626-34. PubMed ID: 7895673 [TBL] [Abstract][Full Text] [Related]
20. The kinin B1 receptor antagonist des-Arg9-[Leu8]bradykinin: an antagonist of the angiotensin AT1 receptor which also binds to the AT2 receptor. Pruneau D; Duvoid A; Luccarini JM; Bélichard P; Bonnafous JC Br J Pharmacol; 1995 Jan; 114(1):115-8. PubMed ID: 7712006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]